Prevalence of ovarian Cancer among women with a CA125 level of 35 U/ml or less[J]. Gynecol Obstet Invest, 2008,65 (2) 133-138.Kobayashi H, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R . 2008b . Prevalence of ovarian cancer among women with a CA125 level of 35U...
Kathleen Moore, MD, discusses the current prevalence of ovarian cancer.Kathleen Moore, MD, director of the Oklahoma TSET Phase I Clinical Trials Program, and associate professor in the Section of Gynecologic Oncology, Jim and Christy Everest Endowed Chair in Cancer Research, director of the Gynecolo...
The prevalence of ovarian cancer with abnormal US was 0.207% among women with a CA125 level of up to 15 U/ml, 0.488% among those with values of 15-20 U/ml, 0.685% among those with values of 20-25 U/ml, 2.04% among those with values of 25-30 U/ml, and 6.12% among those ...
Background: Chlamydia trachomatis (C. trachomatis) and Mycoplasma genitalium (M. genitalium) are considered factors in cervical and ovarian cancer and are associated with flaky cell carcinoma of the cervix. The role of steady infection, leading to chronic inflammation, in the of ovarian cancer has...
However, gene mutations other than BRCA1 and BRCA2 which are shown to increase the risk of hereditary breast and ovarian cancer (HBOC) are underreported.The objective of this study was to estimate the prevalence of deleterious germline mutations among women with breast and/or ovarian cancer.A ...
We conducted a study to determine whether the risk of breast associated with oral contraceptive (OC) use is higher in women with /mutations than in other w... G Ursin,BE Henderson,RW Haile,... - 《Cancer Research》 被引量: 376发表: 1997年 The epidemiology of ovarian cancer: a populatio...
The family history of ovarian cancer (26.7% vs. 11.9%) and stomach cancer (23.8% vs. 11.8%) doubled the incidence of BRCA1/2, but the difference did not reach the statistical significance. Two recurrent mutations in BRCA1, 1100delAT and 5589del8, were identified. The recurrent mutations ...
Multicenter Comparative Multimodality Surveillance of Women at Genetic-Familial High Risk for Breast Cancer (HIBCRIT Study): Interim Results or women enrolled because of a strong family history of breast or ovarian cancer (three or more events in first- or second-degree relatives in either ... S...
families with low prevalence of cancer: experiences of carriers and implications for population screening Shiri Shkedi-Rafid, MSc1,2, Efrat Gabai-Kapara, MSc3,4, Julia Grinshpun-Cohen, MSc4 and Ephrat Levy-Lahad, MD3,4 Purpose: BRCA genes are associated with hereditary breast and ovarian ...
The current estimates of the prevalence of primary ovarian insufficiency (POI) are very variable, but are in most studies believed to be around 1%. It is also very likely tat the prevalence of POI differs between countries and over time. We therefore aimed to assess the prevalence of primary...